| dc.contributor.author | Khan, Rizwan et al. | |
| dc.date.accessioned | 2020-05-15T15:27:54Z | |
| dc.date.available | 2020-05-15T15:27:54Z | |
| dc.date.issued | 2020-05-05 | |
| dc.identifier.uri | https://doi.org/10.3949/ccjm.87a.ccc014 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/1498 | |
| dc.description.abstract | Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in highly selected patients. Expert centers should employ an evidence-based ARDS treatment algorithm and a multidisciplinary approach to recommending ECMO upon failure of conventional therapy. Caring for ECMO patients requires adequate infection control and safety precautions for healthcare workers. | en_US |
| dc.language | English | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Coronavirus | en_US |
| dc.subject | Infectious Diseases | en_US |
| dc.subject | Extracorporeal Membrane Oxygenation | en_US |
| dc.subject | Heart Failure | en_US |
| dc.title | Utility of extracorporeal membrane oxygenation in COVID-19 | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Clinical characterization and management | en_US |
| eihealth.type | Published Article | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.relation.ispartofjournal | Cleveland Clinic Journal of Medicine | en_US |
